Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Lilly Diabetes Donates 91 Scholarships to American Diabetes Association's Summer Camp Program

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3
Lilly Diabetes announced its support for the American Diabetes Association's summer camp program for the seventh year in a row with a donation of $91,000 that will send 91 children to diabetes camp this summer. Since 2008, Lilly Diabetes has supported 531 children attending diabetes camps throughout the US, a scholarship donation totaling over half a million dollars.

Today, there are approximately 130 diabetes camps nationwide. The Association is the single largest operator of US camps for children with diabetes, with 40 camps offering 49 sessions in 25 states each summer. In the last decade, Lilly has donated more than $20 million in insulin and other diabetes medicines, educational materials, volunteers, scholarships, and motivational speakers, making it one of the largest supporters of diabetes camps in the country.

Camp scholarships are awarded by the Association based on financial need.

Source: Lilly Diabetes

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here